SCHEMBL2940445

SCHEMBL2940445

Cc1ccc(S(=O)(=O)N=[S@@](C)c2ccc(N)cc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.84
▸ KMT2A Q03164 2/20 0.71
▸ MEN1 O00255 1/20 0.71
▸ PIR O00625 1/20 0.56
▸ ALDH1A1 P00352 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ LMNA P02545 4/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ RECQL P46063 1/20 0.46
▸ F2 P00734 4/20 0.45
▸ PRSS1 P07477 4/20 0.45
▸ PRSS2 P07478 4/20 0.45
▸ PRSS3 P35030 4/20 0.45
▸ AGO2 Q9UKV8 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1774946 1.00 CYP2C19 (0.84) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL1774945 1.00 CYP2C19 (0.84) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL16317067 0.92 CYP2C19 (1.00) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL17015173 0.92 CYP2C19 (1.00) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL17015171 0.83 KMT2A (1.00) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL17996453 0.83 KMT2A (1.00) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL16317068 0.81 CYP2C19 (0.79) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL17020444 0.81 CYP2C19 (0.79) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL2937262 0.80 CYP2C19 (0.77) CYP2C19KMT2AMEN1PIRALDH1A1
SCHEMBL22217122 0.80 CYP2C19 (0.77) CYP2C19KMT2AMEN1PIRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029552-B1 SULFIMIDES AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AG (DE) 2010-09-22 — — EP disclosed
EP-2029552-A1 SULFIMIDES AS PROTEIN KINASE INHIBITORS Bayer Schering Pharma AG (DE) 2009-03-04 — — EP disclosed
WO-2007140957-A1 SULFIMIDES AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-12-13 — — WO disclosed
Send feedback